Short-term hepatocyte function and portal hypertension outcomes of sofosbuvir/velpatasvir for decompensated hepatitis C-related cirrhosis.

导出 OA

翻译打印收藏纠错

第一作者： Kohei,Kotani

第一单位： Department of Hepatology, Graduate School of Medicine, Osaka Metropolitan University, 1-4-3 Asahimachi, Abeno-ku, Osaka, 545-8585, Japan. kotanikohei@omu.ac.jp.

作者： Kohei,Kotani ^[1] ; Masaru,Enomoto ^[2] ; Sawako,Uchida-Kobayashi ^[2] ; Akihiro,Tamori ^[3] ; Yoshimi,Yukawa-Muto ^[2] ; Naoshi,Odagiri ^[2] ; Hiroyuki,Motoyama ^[2] ; Ritsuzo,Kozuka ^[2] ; Etsushi,Kawamura ^[2] ; Atsushi,Hagihara ^[2] ; Hideki,Fujii ^[2] ; Ken,Kageyama ^[4] ; Akira,Yamamoto ^[4] ; Atsushi,Yoshida ^[5] ; Shigeaki,Higashiyama ^[5] ; Joji,Kawabe ^[5] ; Norifumi,Kawada ^[2]

作者单位： Department of Hepatology, Graduate School of Medicine, Osaka Metropolitan University, 1-4-3 Asahimachi, Abeno-ku, Osaka, 545-8585, Japan. kotanikohei@omu.ac.jp. ^[1] Department of Hepatology, Graduate School of Medicine, Osaka Metropolitan University, 1-4-3 Asahimachi, Abeno-ku, Osaka, 545-8585, Japan. ^[2] Department of Hepatology, Kashiwara Municipal Hospital, 1-7-9 Houzenji, Kashiwara, Osaka, 582-0005, Japan. ^[3] Department of Diagnostic and Interventional Radiology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan. ^[4] Department of Nuclear Medicine, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan. ^[5]

关键词 Hepatitis C Liver cirrhosis Portal hypertension Sofosbuvir Velpatasvir